CIK 0001756262 · Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- Phone
- 9785520900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-01 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,083 | 17,334 | ||
| 2024-10-15 | Hassanein Waleed H President & CEO | Option exercise 10b5-1 | +8,625 | $13.28 | $115K | 70,268 |
| 2024-10-15 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −3,607 | $131.91 | $476K | 66,661 |
| 2024-10-15 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −3,518 | $132.82 | $467K | 63,143 |
| 2024-10-15 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −1,200 | $134.23 | $161K | 61,943 |
| 2024-10-15 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −300 | $135.04 | $41K | 61,643 |
| 2024-10-15 | Hassanein Waleed H President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,625 | 96,250 | ||
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +1,458 | $38.46 | $56K | 22,301 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +417 | $66.10 | $28K | 22,718 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +1,083 | $13.28 | $14K | 23,801 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −823 | $146.15 | $120K | 22,978 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −900 | $146.90 | $132K | 22,078 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −80 | $147.98 | $12K | 21,998 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −523 | $149.59 | $78K | 21,475 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −318 | $150.38 | $48K | 21,157 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −80 | $151.20 | $12K | 21,077 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −80 | $152.28 | $12K | 20,997 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −20 | $153.75 | $3K | 20,977 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −134 | $154.86 | $21K | 20,843 |
| 2024-10-01 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,458 | 7,292 |
Page 6 of 20 · 390 trades